Data analysis of human patients with colon cancer support the hypothesis that SIX4 increases STING/type I IFN signaling and enhances inflammatory responses, which facilitates T-cell infiltration and antitumor immunity. This evidence concerns the gene STING1 and colonic neoplasm.